Xynomic Pharmaceuticals Holdings, Inc. Warrant
XYNPW
XYNPW was delisted on the 16th of July, 2019.
12 hedge funds and large institutions have $184K invested in Xynomic Pharmaceuticals Holdings, Inc. Warrant in 2019 Q2 according to their latest regulatory filings, with 12 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$46.1K |
| 2 |
VAS
VR Advisory Services
Camana Bay, Grand Cayman,
Cayman Islands
|
+$26.2K |
| 3 |
ICM
Ionic Capital Management
New York
|
+$19.8K |
| 4 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$14.6K |
| 5 |
Walleye Trading
New York
|
+$13.1K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PAMP
1
Polar Asset Management Partners
Toronto,
Ontario, Canada
| $50K | +$46.1K | +236,873 | New |
|
|
VAS
2
VR Advisory Services
Camana Bay, Grand Cayman,
Cayman Islands
| $28K | +$26.2K | +134,748 | New |
|
|
ICM
3
Ionic Capital Management
New York
| $21K | +$19.8K | +101,533 | New |
|
|
AA
4
AQR Arbitrage
Greenwich,
Connecticut
| $16K | +$14.6K | +75,000 | New |
|
|
5
Walleye Trading
New York
| $14K | +$13.1K | +67,211 | New |
|
|
CCM
6
Context Capital Management
Lajolla,
California
| $13K | +$12.3K | +63,000 | New |
|
|
6CM
7
683 Capital Management
New York
| $11K | +$9.73K | +50,000 | New |
|
|
CI
8
Cowen Inc
New York
| $11K | +$9.73K | +50,000 | New |
|
|
YCM
9
Yakira Capital Management
Westport,
Connecticut
| $11K | +$9.73K | +50,000 | New |
|
|
WAM
10
Wolverine Asset Management
Chicago,
Illinois
| $5K | +$4.81K | +24,703 | New |
|
|
PC
11
Periscope Capital
Toronto,
Ontario, Canada
| $4K | +$3.95K | +20,300 | New |
|
|
BI
12
Bulldog Investors
Saddle Brook,
New Jersey
| $11 | +$9.73K | +50,000 | New |
|
XYNPW Hedge Fund Activity: Q2 2019 in Review
12 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Xynomic Pharmaceuticals Holdings, Inc. Warrant (XYNPW) for Q2 2019, worth a combined $184K.
Buyers outnumbered sellers: 12 funds opened new XYNPW positions and 0 closed out — a net gain of 12 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Polar Asset Management Partners, opening a new position worth an estimated $46.1K.
- 12 institutional investors held Xynomic Pharmaceuticals Holdings, Inc. Warrant (XYNPW) as of Q2 2019, up from 0 in Q1 2019.
- Funds reported $184K of Xynomic Pharmaceuticals Holdings, Inc. Warrant stock for Q2 2019.
- 12 funds opened new Xynomic Pharmaceuticals Holdings, Inc. Warrant positions in Q2 2019 and 0 closed out, a net change of +12 holders.
- The largest Xynomic Pharmaceuticals Holdings, Inc. Warrant buyer in Q2 2019 was Polar Asset Management Partners, an estimated $46.1K added.
Based on aggregated 13F filings for Q2 2019.